WELL Health Technologies (TSE:WELL - Get Free Report) had its price objective decreased by stock analysts at Ventum Financial from C$8.00 to C$7.00 in a note issued to investors on Tuesday, BayStreet.CA reports. The firm presently has a "buy" rating on the stock. Ventum Financial's target price indicates a potential upside of 60.18% from the company's previous close.
Separately, CIBC increased their target price on WELL Health Technologies from C$4.75 to C$5.00 in a research note on Friday, August 16th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of C$6.97.
View Our Latest Stock Report on WELL
WELL Health Technologies Price Performance
Shares of WELL remained flat at C$4.37 during trading hours on Tuesday. The company had a trading volume of 398,883 shares, compared to its average volume of 791,389. WELL Health Technologies has a fifty-two week low of C$3.41 and a fifty-two week high of C$5.05. The company has a market cap of C$1.09 billion, a PE ratio of 7.67, a PEG ratio of -1.93 and a beta of 1.20. The company's fifty day moving average price is C$4.45 and its two-hundred day moving average price is C$4.27. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02.
About WELL Health Technologies
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
See Also
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.